FDA Adverse Event Injury Summary report: N

MODULAR HEAD COCR

MDR report key: 6601135 · Received May 31, 2017

Report

Report Number
0001825034-2017-03479
Event Type
Injury
Date Received
May 31, 2017
Date of Event
November 23, 2015
Report Date
January 25, 2018
Manufacturer
BIOMET ORTHOPEDICS
Product Code
KWA
PMA / PMN Number
PNI
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE DEVICE WILL NOT BE RETURNED FOR ANALYSIS; HOWEVER, AN INVESTIGATION OF THE REPORTED EVENT IS IN PROGRESS. ONCE THE INVESTIGATION IS COMPLETED, A SUPPLEMENTAL MDR WILL BE SUBMITTED. CONCOMITANT MEDICAL PRODUCTS: - ARCOS HA MODULAR REVISION SYSTEM CONE PROXIMAL BODY/TYPE I TAPER, P/N 22-301301, L/N 725630. ARCOS HA MODULAR REVISION SYSTEM STRAIGHT TAPERED SPLINED DISTAL STEM, P/N 22-300814 L/N, 296080. ACETABULAR SHELL REGENEREX POROUS TITANIUM CONSTRUCT, P/N PT-124858, L/N 642120. ADVANTAGE LINER, P/N P0860044, L/N 0000900990. REPORT SOURCE: (B)(6). MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT. PLEASE SEE ASSOCIATED REPORTS: 0001825034-2017-03474, 0001825034-2017-03477, 0001825034-2017-03478, 0001825034-2017-03479.

Additional Manufacturer Narrative · 1

UPON REASSESSMENT OF THE REPORTED EVENT, IT WAS DETERMINED THAT THIS DEVICE DID NOT CAUSE OR CONTRIBUTE TO THE EVENT AND SHOULD NOT HAVE BEEN REPORTED. THE INITIAL REPORT SHOULD BE VOIDED AS IT WAS SUBMITTED IN ERROR. THIS EVENT HAS BEEN REPORTED IN 3006946279-2017-00143.

Description of Event or Problem · 1

IT WAS REPORTED THAT PATIENT UNDERWENT IRRIGATION, DEBRIDEMENT AND ANTIBIOTIC TREATMENT ONE MONTH POST-IMPLANTATION DUE TO WOUND DEHISCENCE. NO PRODUCTS WERE REPORTED TO HAVE BEEN REVISED. ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION HAVE BEEN MADE; HOWEVER, NO MORE IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
383657 MODULAR HEAD COCR PROSTHESIS, HIP KWA BIOMET ORTHOPEDICS N/A 00J3315968

Patients

Seq Age Sex Outcome Treatment
1 84 YR Required Intervention